GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Oncotherapy PLC (FRA:R3I1) » Definitions » Float Percentage Of Total Shares Outstanding

Advanced Oncotherapy (FRA:R3I1) Float Percentage Of Total Shares Outstanding : 0.00% (As of Jun. 05, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Advanced Oncotherapy Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Advanced Oncotherapy's float shares is 0.00 Mil. Advanced Oncotherapy's total shares outstanding is 542.57 Mil. Advanced Oncotherapy's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Advanced Oncotherapy's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Advanced Oncotherapy's Institutional Ownership is 2.36%.

Advanced Oncotherapy Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Advanced Oncotherapy's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/542.57
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced Oncotherapy (FRA:R3I1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Oncotherapy PLC (FRA:R3I1) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
LSE:SUN LSE:MHC LSE:RUA LSE:DEMG LSE:POLX LSE:IHC LSE:IUG LSE:BELL ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH ALGN STE XAMS:PHIA XSWX:SOON
Traded in Other Exchanges
N/A
Address
4 Tenterden Street, Third Floor, London, GBR, W1S 1TE
Website
https://www.avoplc.com
Advanced Oncotherapy PLC is active in the healthcare domain in the United Kingdom. As a medical care provider, its focus is to develop technologies to maximize the destructive effect of radiation on tumors whilst minimizing damage to healthy tissues. It develops an affordable proton-based radiotherapy system, using innovative and clinically effective technology, thereby contributing to curing critical unmet conditions. The company's only business segment is Proton Therapy.

Advanced Oncotherapy (FRA:R3I1) Headlines

No Headlines